The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.


Updates from The Motley Fool

Latest updates on Eli Lilly and Co. from Fool.com.  The Fool has written over 800 articles on Eli Lilly and Co..
2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...

Why Eli Lilly Is Cratering Today

Shares fall by double digits in response to disappointing news from an important clinical trial.

3 Healthcare Stocks We Won't Buy

Our team of healthcare contributors think that these healthcare stocks should be avoided at all c...



Stock Performance

View Interactive LLY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Eli Lilly and Co..
Current Price: $84.17
Prev Close: $84.18
Open: $83.90
Bid: $84.15
Ask: $84.20
Day's Range: $83.74 - $84.35
52wk Range: $64.18 - $86.14
Volume: 311,392
Avg Vol 3,721,693
Market Cap: $93B
P/E (ttm): 32.63
EPS (ttm): $2.58
Div & Yield: $2.08 (2.5%)

Company Rating

What our community thinks about Eli Lilly and Co..
CAPS Rating 4 out of 5
 
1218 Outperform
104 Underperform
CAPS All Stars
 
344 Outperform
19 Underperform

How do you think Eli Lilly and Co. will perform against the market?



You pick for Eli Lilly and Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John C. Lechleiter, CEO

90% Approve

Based on 602 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Eli Lilly and Co..

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers